Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Developments in Ophthalmology|October 27, 2015
Ocular Angiogenesis: Vascular Endothelial Growth Factor and Other FactorsRoman G Rubio, Anthony P Adamis
Ophthalmology|February 19, 2013
Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomographyRobert B Bhisitkul, Peter A Campochiaro, Howard Shapiro, et al.
Ophthalmology|December 25, 2012
Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusionPeter A Campochiaro, Robert B Bhisitkul, Howard Shapiro, et al.
Retina (Philadelphia, Pa.)|July 22, 2014
Collateral vessel presence in branch and central retinal vein occlusions and their impact on visual acuity and anatomical gains: a retrospective analysisRishi P Singh, Tamara J Lee, Linda Yau, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 16, 2011
Myocardial infarction and cerebrovascular accident in patients with retinal vein occlusionWinifred Werther, Laura Chu, Nancy Holekamp, et al.
Ophthalmology|April 29, 2014
Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edemaPeter A Campochiaro, Charles C Wykoff, Howard Shapiro, et al.
Drugs|November 17, 2021
Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type ANowell Solish, Jean Carruthers, Joely Kaufman, et al.
Ophthalmology|February 4, 2012
Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trialJeffrey S Heier, Peter A Campochiaro, Linda Yau, et al.
Ophthalmology|August 1, 2009
A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degenerationDavid S Boyer, Jeffrey S Heier, David M Brown, et al.
Aesthetic Surgery Journal|September 10, 2022
Efficacy and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Glabellar Lines by Age and Race: Subgroup Analysis of the SAKURA Clinical TrialsNowell Solish, Cheryl M Burgess, Susan H Weinkle, et al.
Pageof 4